Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of the Polaris® 24 Adjustable Valve System in Hydrocephalus Patients' Treatment

NCT04746625 is registered in ClinicalTrials.gov with Sophysa as lead sponsor.

NCT NCT04746625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04746625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of the Polaris® 24 Adjustable Valve System in Hydrocephalus Patients' Treatment
Lead sponsor
Sophysa
Phase
Observational
Overall status
Recruiting
Start date
June 4, 2021
Completion date
June 30, 2033
Enrollment
126 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hydrocephalus